Table 3.

The curative effect of the compounds 3a–x against TMV in vivo.

Agent	Concentration (μg/mL)	Curative Effect (%)
3a	500	43.2
3b	500	38.4
3c	500	32.0
3d	500	37.8
3e	500	31.9
3f	500	30.1
3g	500	35.9
3h	500	33.0
3i	500	33.9
3j	500	36.0
3k	500	31.9
3l	500	38.0
3m	500	44.0
3n	500	45.6
3o	500	41.2
3p	500	52.0
3q	500	49.1
3r	500	40.1
3v	500	51.9
3w	500	44.8
3x	500	47.9
Ningnanmycin	500	55.9